XML 56 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Equity-Based Compensation  
Summary of allocation of equity-based compensation

The Company recorded equity-based compensation expense related to all equity-based awards, which was allocated as follows in the consolidated statements of operations and comprehensive loss for the years ended December 31, 2020 and 2019 (in thousands):

Year Ended

December 31, 

    

2020

    

2019

Research and development expense

$

3,554

$

2,425

General and administrative expense

 

7,621

 

5,547

$

11,175

$

7,972

Summary of restricted common stock activity

    

    

Weighted

Average Fair

Value per Share

    

Number of Shares

    

at Issuance

Restricted common stock as of December 31, 2019

 

302,360

$

5.77

Granted

 

$

Vested

 

(202,381)

$

5.77

Forfeited

 

(42,010)

$

5.77

Restricted common stock as of December 31, 2020

 

57,969

$

5.77

Summary of stock option activity

Weighted

Weighted

Average

Number of 

Average

Remaining

Aggregate

    

Shares

    

Exercise Price

    

Contractual Term

    

Intrinsic Value

(in years)

(in thousands)

Outstanding as of December 31, 2019

 

2,401,382

$

12.63

 

8.36

$

6,523

Granted

 

2,388,340

$

16.01

Exercised

(676,649)

$

10.78

Cancelled

 

(433,142)

$

14.38

Outstanding as of December 31, 2020

 

3,679,931

$

14.96

8.01

$

123,600

Options exercisable as of December 31, 2020

 

900,142

$

13.72

7.76

$

31,332

Schedule of fair value assumptions

Year Ended

December 31, 

2020

    

2019

Risk-free interest rate

0.92

%  

2.31

%

Expected dividend yield

0.0

%  

0.0

%

Expected term (years to liquidity)

6.21

6.20

Expected volatility

82.09

%  

79.50

%